Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genetic variation in VTCN1 (B7-H4) is associated with course of disease in juvenile idiopathic arthritis.
Albers HM, Reinards TH, Brinkman DM, Kamphuis SS, van Rossum MA, Hoppenreijs EP, Girschick HJ, Wouters C, Saurenmann RK, Bakker E, Verduijn W, Slagboom P, Huizinga TW, Toes RE, Houwing-Duistermaat JJ, ten Cate R, Schilham MW. Albers HM, et al. Among authors: hoppenreijs ep. Ann Rheum Dis. 2014 Jun;73(6):1198-201. doi: 10.1136/annrheumdis-2013-204466. Epub 2013 Dec 17. Ann Rheum Dis. 2014. PMID: 24347572
Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis.
Heijstek MW, Pileggi GC, Zonneveld-Huijssoon E, Armbrust W, Hoppenreijs EP, Uiterwaal CS, Kuis W, Wulffraat NM. Heijstek MW, et al. Among authors: hoppenreijs ep. Ann Rheum Dis. 2007 Oct;66(10):1384-7. doi: 10.1136/ard.2006.063586. Epub 2007 Feb 6. Ann Rheum Dis. 2007. PMID: 17284544 Free PMC article.
Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register.
Prince FH, Twilt M, ten Cate R, van Rossum MA, Armbrust W, Hoppenreijs EP, van Santen-Hoeufft M, Koopman-Keemink Y, Wulffraat NM, van Suijlekom-Smit LW. Prince FH, et al. Among authors: hoppenreijs ep. Ann Rheum Dis. 2009 May;68(5):635-41. doi: 10.1136/ard.2007.087411. Epub 2008 Apr 15. Ann Rheum Dis. 2009. PMID: 18413443 Clinical Trial.
Development of a web-based register for the Dutch national study on biologicals in JIA: www.ABC-register.nl.
Prince FH, Ferket IS, Kamphuis S, Armbrust W, Ten Cate R, Hoppenreijs EP, Koopman-Keemink Y, van Rossum MA, van Santen-Hoeufft M, Twilt M, van Suijlekom-Smit LW. Prince FH, et al. Among authors: hoppenreijs ep. Rheumatology (Oxford). 2008 Sep;47(9):1413-6. doi: 10.1093/rheumatology/ken245. Epub 2008 Jul 16. Rheumatology (Oxford). 2008. PMID: 18632789
When and how to stop etanercept after successful treatment of patients with juvenile idiopathic arthritis.
Prince FH, Twilt M, Simon SC, van Rossum MA, Armbrust W, Hoppenreijs EP, Kamphuis S, van Santen-Hoeufft M, Koopman-Keemink Y, Wulffraat NM, ten Cate R, van Suijlekom-Smit LW. Prince FH, et al. Among authors: hoppenreijs ep. Ann Rheum Dis. 2009 Jul;68(7):1228-9. doi: 10.1136/ard.2008.101030. Ann Rheum Dis. 2009. PMID: 19525408 No abstract available.
Major improvements in health-related quality of life during the use of etanercept in patients with previously refractory juvenile idiopathic arthritis.
Prince FH, Geerdink LM, Borsboom GJ, Twilt M, van Rossum MA, Hoppenreijs EP, Cate RT, Koopman-Keemink Y, van Santen-Hoeufft M, Raat H, van Suijlekom-Smit LW. Prince FH, et al. Among authors: hoppenreijs ep. Ann Rheum Dis. 2010 Jan;69(1):138-42. doi: 10.1136/ard.2009.111260. Ann Rheum Dis. 2010. PMID: 19581280
Clinical course and prognostic value of disease activity in the first two years in different subtypes of juvenile idiopathic arthritis.
Albers HM, Brinkman DM, Kamphuis SS, van Suijlekom-Smit LW, van Rossum MA, Hoppenreijs EP, Girschick HJ, Wouters C, Saurenmann RK, Houwing-Duistermaat JJ, Huizinga TW, Schilham MW, ten Cate R. Albers HM, et al. Among authors: hoppenreijs ep. Arthritis Care Res (Hoboken). 2010 Feb;62(2):204-12. doi: 10.1002/acr.20069. Arthritis Care Res (Hoboken). 2010. PMID: 20191519 Free article.
Tumour necrosis factor (TNF)-blocking agents in juvenile psoriatic arthritis: are they effective?
Otten MH, Prince FH, Ten Cate R, van Rossum MA, Twilt M, Hoppenreijs EP, Koopman-Keemink Y, Oranje AP, de Waard-van der Spek FB, Gorter SL, Armbrust W, Dolman KM, Wulffraat NM, van Suijlekom-Smit LW. Otten MH, et al. Among authors: hoppenreijs ep. Ann Rheum Dis. 2011 Feb;70(2):337-40. doi: 10.1136/ard.2010.135731. Epub 2010 Nov 10. Ann Rheum Dis. 2011. PMID: 21068101 Clinical Trial.
64 results